CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: desogestrel
Accession: CHEBI:4453
browse the term
Definition: A terminal acetylenic compound that has formula C22H30O.
Synonyms: exact_synonym: 17alpha-ethynyl-11-methylidene-18a-homo-estr-4-en-17beta-ol
related_synonym: 13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol; Cerazette; Formula=C22H30O; InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1; InChIKey=RPLCPCMSCLEKRS-BPIQYHPVSA-N; SMILES=[H][C@]12CCCC=C1CC[C@@]1([H])[C@]3([H])CC[C@@](O)(C#C)[C@@]3(CC)CC(=C)[C@]21[H]; desogestrelum
xref: Beilstein:5094648; CAS:54024-22-5; DrugBank:DB00304; Drug_Central:818; KEGG:C07629; KEGG:D02367; LIPID_MAPS_instance:LMST02030104
xref_mesh: MESH:D017135
xref: Patent:DE2361120; Patent:US3927046; Wikipedia:Desogestrel
G
Akr1c3
aldo-keto reductase family 1, member C3
decreases activity
ISO
Desogestrel results in decreased activity of AKR1C3 protein
CTD
PMID:21182831
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Apoe
apolipoprotein E
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of APOE mRNA
CTD
PMID:18160741
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Cat
catalase
multiple interactions
ISO
[Ethinyl Estradiol co-treated with Desogestrel] results in decreased activity of CAT protein
CTD
PMID:17541152
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccn5
cellular communication network factor 5
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CCN5 mRNA
CTD
PMID:18160741
NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636
G
Cpb2
carboxypeptidase B2
increases activity
ISO
Desogestrel results in increased activity of CPB2 protein
CTD
PMID:11301170
NCBI chr15:50,557,722...50,606,569
Ensembl chr15:50,557,717...50,606,556
G
Crp
C-reactive protein
multiple interactions
ISO
[Ethinyl Estradiol co-treated with Desogestrel] results in increased expression of CRP protein; Simvastatin inhibits the reaction [[Ethinyl Estradiol co-treated with Desogestrel] results in increased expression of CRP protein]
CTD
PMID:17105841
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cst9l
cystatin 9-like
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in increased expression of CST9L mRNA
CTD
PMID:18160741
NCBI chr 3:136,288,093...136,290,906
Ensembl chr 3:136,288,093...136,290,906
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP11A1 mRNA
CTD
PMID:18160741
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of CYP17A1 mRNA
CTD
PMID:18160741
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity
ISO
Desogestrel results in decreased activity of CYP1A2 protein
CTD
PMID:18816299
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Ddr1
discoidin domain receptor tyrosine kinase 1
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in increased expression of DDR1 mRNA
CTD
PMID:18160741
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Dhcr24
24-dehydrocholesterol reductase
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DHCR24 mRNA
CTD
PMID:18160741
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Dpep3
dipeptidase 3
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA
CTD
PMID:18160741
NCBI chr19:33,868,229...33,876,609
Ensembl chr19:33,868,242...33,873,896
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of HMGCS2 mRNA
CTD
PMID:18160741
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Insl3
insulin-like 3
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of INSL3 mRNA
CTD
PMID:18160741
NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560
G
Ldlr
low density lipoprotein receptor
multiple interactions increases expression
ISO
[Desogestrel co-treated with Ethinyl Estradiol] results in increased expression of LDLR protein Desogestrel results in increased expression of LDLR protein
CTD
PMID:17900441
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lhb
luteinizing hormone subunit beta
multiple interactions
ISO
[Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of LHB protein; Simvastatin promotes the reaction [[Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of LHB protein]
CTD
PMID:17105841
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of PAPSS2 mRNA
CTD
PMID:18160741
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Pgr
progesterone receptor
multiple interactions
ISO
Desogestrel binds to and affects the activity of PGR protein
CTD
PMID:15697108
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pgrmc1
progesterone receptor membrane component 1
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of PGRMC1 mRNA
CTD
PMID:18160741
NCBI chr X:115,832,865...115,841,060
Ensembl chr X:115,832,884...115,888,682
G
Pon1
paraoxonase 1
multiple interactions
ISO
[Ethinyl Estradiol co-treated with Desogestrel] affects the activity of PON1 protein
CTD
PMID:17541152
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Proc
protein C, inactivator of coagulation factors Va and VIIIa
decreases activity
ISO
Desogestrel results in decreased activity of PROC protein
CTD
PMID:11301170
NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
G
Prok1
prokineticin 1
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of PROK1 mRNA
CTD
PMID:18160741
NCBI chr 2:194,850,539...194,859,343
Ensembl chr 2:194,853,991...194,859,250
G
Pros1
protein S
affects expression
ISO
Desogestrel affects the expression of PROS1 protein
CTD
PMID:11442481
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Rhob
ras homolog family member B
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of RHOB mRNA
CTD
PMID:18160741
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
Sycp1
synaptonemal complex protein 1
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of SYCP1 mRNA
CTD
PMID:18160741
NCBI chr 2:190,296,688...190,456,687
Ensembl chr 2:190,296,954...190,456,737
G
Taf4b
TATA-box binding protein associated factor 4b
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of TAF4B mRNA
CTD
PMID:18160741
NCBI chr18:5,952,737...6,086,408
Ensembl chr18:5,952,769...6,068,307
G
Tex19.2
testis expressed gene 19.2
multiple interactions
ISO
[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of TEX19 mRNA
CTD
PMID:18160741
NCBI chr10:106,379,757...106,382,344
Ensembl chr10:106,379,757...106,382,344
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
[Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of VCAM1 protein; Simvastatin promotes the reaction [[Ethinyl Estradiol co-treated with Desogestrel] results in decreased expression of VCAM1 protein]
CTD
PMID:17105841
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all